Literature DB >> 27624121

The clinical spectrum and natural history of pure akinesia with gait freezing.

Emily Owens1, Keith A Josephs2, Rodolfo Savica2, Anhar Hassan2, Bryan Klassen2, James Bower2, Demetrius Maraganore3, Joseph Matsumoto2, J E Ahlskog2.   

Abstract

Gait freezing as a presenting and relatively restricted condition is uncommon but a distinctive disorder. This entity was initially defined as "pure akinesia with gait freezing", and later a neuropathological substrate of progressive supranuclear palsy has been recognized. Limited studies have reported the clinical evolution after presentation, which is important for patient counseling. The objective of this study was to assess the demographic and clinical features, treatment-response, neuroimaging, and evolution of pure akinesia with gait freezing. A retrospective review of patients with this phenotype as previously defined was performed. Patients included had no or minimal limb rigidity and/or bradykinesia and no resting tremor, and all underwent neuroimaging of the brain after onset. Inclusion criteria were met by 30 patients, who were followed up to 21 years after symptom onset. During their course, 28 patients had falls (93 %), 12 patients had dysarthria (40 %), and 13 had handwriting changes (43 %). All patients had progression of their gait disorder over time, but with a variable interval until falls occurred. None of the patients developed vertical gaze palsy or met diagnostic criteria for an alternative parkinsonian disorder. Pure akinesia with gait freezing is a distinctive disorder that can be recognized in the clinic. Despite the previously reported progressive supranuclear palsy-like neuropathology, the clinical course is much less aggressive and disabling than classic Richardson syndrome, although fall risk eventually develops in nearly all patients. Bradykinesia, tremor, and rigidity do not develop, distinguishing pure akinesia with gait freezing from Parkinson's disease and other parkinsonian disorders.

Entities:  

Keywords:  Falls; Gait freezing; PAGF; PSP

Mesh:

Substances:

Year:  2016        PMID: 27624121     DOI: 10.1007/s00415-016-8278-x

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  11 in total

1.  The natural history of the syndrome of primary progressive freezing gait.

Authors:  Stewart A Factor; Danna L Jennings; Eric S Molho; Kenneth L Marek
Journal:  Arch Neurol       Date:  2002-11

2.  Dopa-unresponsive pure akinesia or freezing. A condition within a wide spectrum of PSP?

Authors:  H Imai; T Nakamura; T Kondo; H Narabayashi
Journal:  Adv Neurol       Date:  1993

3.  Primary progressive freezing gait.

Authors:  A Achiron; I Ziv; M Goren; H Goldberg; Y Zoldan; H Sroka; E Melamed
Journal:  Mov Disord       Date:  1993-07       Impact factor: 10.338

Review 4.  Freezing of gait: moving forward on a mysterious clinical phenomenon.

Authors:  John G Nutt; Bastiaan R Bloem; Nir Giladi; Mark Hallett; Fay B Horak; Alice Nieuwboer
Journal:  Lancet Neurol       Date:  2011-08       Impact factor: 44.182

Review 5.  The clinical spectrum of freezing of gait in atypical parkinsonism.

Authors:  Stewart A Factor
Journal:  Mov Disord       Date:  2008       Impact factor: 10.338

6.  The syndrome of 'pure akinesia' and its relationship to progressive supranuclear palsy.

Authors:  D E Riley; N Fogt; R J Leigh
Journal:  Neurology       Date:  1994-06       Impact factor: 9.910

7.  Long lasting pure freezing of gait preceding progressive supranuclear palsy: a clinicopathological study.

Authors:  Yaroslau Compta; Francesc Valldeoriola; Eduardo Tolosa; María Jesús Rey; María José Martí; Josep Valls-Solé
Journal:  Mov Disord       Date:  2007-10-15       Impact factor: 10.338

8.  Akinesia and axial rigidity without limb rigidity: an intermediate form between progressive supranuclear palsy and pure akinesia of Imai and Narabayashi.

Authors:  Y Nakajima; K Matsuda; Y Mizuno
Journal:  Parkinsonism Relat Disord       Date:  1996-10       Impact factor: 4.891

9.  Clinicopathological characteristics of freezing of gait in autopsy-confirmed Parkinson's disease.

Authors:  Tuhin Virmani; Carol B Moskowitz; Jean-Paul Vonsattel; Stanley Fahn
Journal:  Mov Disord       Date:  2015-08-03       Impact factor: 10.338

10.  Pure akinesia with gait freezing: a third clinical phenotype of progressive supranuclear palsy.

Authors:  David R Williams; Janice L Holton; Kate Strand; Tamas Revesz; Andrew J Lees
Journal:  Mov Disord       Date:  2007-11-15       Impact factor: 10.338

View more
  11 in total

1.  Sensitivity and Specificity of Diagnostic Criteria for Progressive Supranuclear Palsy.

Authors:  Farwa Ali; Peter R Martin; Hugo Botha; J Eric Ahlskog; James H Bower; Joseph Y Masumoto; Demetrius Maraganore; Anhar Hassan; Scott Eggers; Bradley F Boeve; David S Knopman; Daniel Drubach; Ronald C Petersen; Erika Driver Dunkley; Jay van Gerpen; Ryan Uitti; Jennifer L Whitwell; Dennis W Dickson; Keith A Josephs
Journal:  Mov Disord       Date:  2019-02-06       Impact factor: 10.338

Review 2.  Advances in progressive supranuclear palsy: new diagnostic criteria, biomarkers, and therapeutic approaches.

Authors:  Adam L Boxer; Jin-Tai Yu; Lawrence I Golbe; Irene Litvan; Anthony E Lang; Günter U Höglinger
Journal:  Lancet Neurol       Date:  2017-06-13       Impact factor: 44.182

3.  Diagnostic accuracy of MRI parameters in pure akinesia with gait freezing.

Authors:  Keiichi Nakahara; Shunya Nakane; Mika Kitajima; Tomoko Masuda-Narita; Hidenori Matsuo; Yukio Ando
Journal:  J Neurol       Date:  2019-11-19       Impact factor: 4.849

4.  Brainstem Biomarkers of Clinical Variant and Pathology in Progressive Supranuclear Palsy.

Authors:  Rosalie M Grijalva; Nha Trang Thu Pham; Qiao Huang; Peter R Martin; Farwa Ali; Heather M Clark; Joseph R Duffy; Rene L Utianski; Hugo Botha; Mary M Machulda; Stephen D Weigand; J Eric Ahlskog; Dennis W Dickson; Keith A Josephs; Jennifer L Whitwell
Journal:  Mov Disord       Date:  2021-12-31       Impact factor: 9.698

5.  Utility of the Movement Disorders Society Criteria for Progressive Supranuclear Palsy in Clinical Practice.

Authors:  Farwa Ali; Hugo Botha; Jennifer L Whitwell; Keith A Josephs
Journal:  Mov Disord Clin Pract       Date:  2019-07-24

Review 6.  Evolving concepts in progressive supranuclear palsy and other 4-repeat tauopathies.

Authors:  Maria Stamelou; Gesine Respondek; Nikolaos Giagkou; Jennifer L Whitwell; Gabor G Kovacs; Günter U Höglinger
Journal:  Nat Rev Neurol       Date:  2021-08-23       Impact factor: 42.937

7.  Brain volume and flortaucipir analysis of progressive supranuclear palsy clinical variants.

Authors:  Jennifer L Whitwell; Nirubol Tosakulwong; Hugo Botha; Farwa Ali; Heather M Clark; Joseph R Duffy; Rene L Utianski; Chase A Stevens; Stephen D Weigand; Christopher G Schwarz; Matthew L Senjem; Clifford R Jack; Val J Lowe; J Eric Ahlskog; Dennis W Dickson; Keith A Josephs
Journal:  Neuroimage Clin       Date:  2019-12-28       Impact factor: 4.881

Review 8.  Differential Diagnosis of Rare Subtypes of Progressive Supranuclear Palsy and PSP-Like Syndromes-Infrequent Manifestations of the Most Common Form of Atypical Parkinsonism.

Authors:  Patrycja Krzosek; Natalia Madetko; Anna Migda; Bartosz Migda; Dominika Jaguś; Piotr Alster
Journal:  Front Aging Neurosci       Date:  2022-02-09       Impact factor: 5.750

9.  The Application of Deep Brain Stimulation for Progressive Supranuclear Palsy: A Systematic Review.

Authors:  Yafei Wen; Bin Jiao; Yafang Zhou
Journal:  Front Neurol       Date:  2022-06-02       Impact factor: 4.086

Review 10.  Clinical Spectrum of Tauopathies.

Authors:  Nahid Olfati; Ali Shoeibi; Irene Litvan
Journal:  Front Neurol       Date:  2022-07-14       Impact factor: 4.086

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.